Cargando…
Corrigendum: High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020904/ https://www.ncbi.nlm.nih.gov/pubmed/33831136 http://dx.doi.org/10.3389/fimmu.2021.671443 |
| _version_ | 1783674647018995712 |
|---|---|
| author | Cao, Wei Liu, Xiaosheng Hong, Ke Ma, Zhiyong Zhang, Yuelun Lin, Ling Han, Yang Xiong, Yong Liu, Zhengyin Ruan, Lianguo Li, Taisheng |
| author_facet | Cao, Wei Liu, Xiaosheng Hong, Ke Ma, Zhiyong Zhang, Yuelun Lin, Ling Han, Yang Xiong, Yong Liu, Zhengyin Ruan, Lianguo Li, Taisheng |
| author_sort | Cao, Wei |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8020904 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80209042021-04-06 Corrigendum: High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China Cao, Wei Liu, Xiaosheng Hong, Ke Ma, Zhiyong Zhang, Yuelun Lin, Ling Han, Yang Xiong, Yong Liu, Zhengyin Ruan, Lianguo Li, Taisheng Front Immunol Immunology Frontiers Media S.A. 2021-03-22 /pmc/articles/PMC8020904/ /pubmed/33831136 http://dx.doi.org/10.3389/fimmu.2021.671443 Text en Copyright © 2021 Cao, Liu, Hong, Ma, Zhang, Lin, Han, Xiong, Liu, Ruan and Li https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Immunology Cao, Wei Liu, Xiaosheng Hong, Ke Ma, Zhiyong Zhang, Yuelun Lin, Ling Han, Yang Xiong, Yong Liu, Zhengyin Ruan, Lianguo Li, Taisheng Corrigendum: High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China |
| title | Corrigendum: High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China |
| title_full | Corrigendum: High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China |
| title_fullStr | Corrigendum: High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China |
| title_full_unstemmed | Corrigendum: High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China |
| title_short | Corrigendum: High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China |
| title_sort | corrigendum: high-dose intravenous immunoglobulin in severe coronavirus disease 2019: a multicenter retrospective study in china |
| topic | Immunology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020904/ https://www.ncbi.nlm.nih.gov/pubmed/33831136 http://dx.doi.org/10.3389/fimmu.2021.671443 |
| work_keys_str_mv | AT caowei corrigendumhighdoseintravenousimmunoglobulininseverecoronavirusdisease2019amulticenterretrospectivestudyinchina AT liuxiaosheng corrigendumhighdoseintravenousimmunoglobulininseverecoronavirusdisease2019amulticenterretrospectivestudyinchina AT hongke corrigendumhighdoseintravenousimmunoglobulininseverecoronavirusdisease2019amulticenterretrospectivestudyinchina AT mazhiyong corrigendumhighdoseintravenousimmunoglobulininseverecoronavirusdisease2019amulticenterretrospectivestudyinchina AT zhangyuelun corrigendumhighdoseintravenousimmunoglobulininseverecoronavirusdisease2019amulticenterretrospectivestudyinchina AT linling corrigendumhighdoseintravenousimmunoglobulininseverecoronavirusdisease2019amulticenterretrospectivestudyinchina AT hanyang corrigendumhighdoseintravenousimmunoglobulininseverecoronavirusdisease2019amulticenterretrospectivestudyinchina AT xiongyong corrigendumhighdoseintravenousimmunoglobulininseverecoronavirusdisease2019amulticenterretrospectivestudyinchina AT liuzhengyin corrigendumhighdoseintravenousimmunoglobulininseverecoronavirusdisease2019amulticenterretrospectivestudyinchina AT ruanlianguo corrigendumhighdoseintravenousimmunoglobulininseverecoronavirusdisease2019amulticenterretrospectivestudyinchina AT litaisheng corrigendumhighdoseintravenousimmunoglobulininseverecoronavirusdisease2019amulticenterretrospectivestudyinchina |